
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12754132
[patent_doc_number] => 20180143211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/854445
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15854445
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/854445 | ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF | Dec 25, 2017 | Abandoned |
Array
(
[id] => 12641202
[patent_doc_number] => 20180105565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => Compositions and Methods for Inhibiting Tumor Cells by Inhibiting the Transcription Factor ATF5
[patent_app_type] => utility
[patent_app_number] => 15/853087
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853087
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853087 | Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5 | Dec 21, 2017 | Issued |
Array
(
[id] => 15895307
[patent_doc_number] => 20200147172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => USE OF CREG IN TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/474903
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474903
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474903 | USE OF CREG IN TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES | Dec 20, 2017 | Abandoned |
Array
(
[id] => 12881134
[patent_doc_number] => 20180185553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => COLLAGEN COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/851732
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15851732
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/851732 | Collagen compositions and methods of use | Dec 20, 2017 | Issued |
Array
(
[id] => 13339829
[patent_doc_number] => 20180221454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => THIOREDOXIN, THIOREDOXIN PEPTIDES OR DERIVATIVES FOR TREATMENT OF AGE-RELATED HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 15/845376
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15845376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/845376 | THIOREDOXIN, THIOREDOXIN PEPTIDES OR DERIVATIVES FOR TREATMENT OF AGE-RELATED HYPERTENSION | Dec 17, 2017 | Abandoned |
Array
(
[id] => 12908947
[patent_doc_number] => 20180194824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => MUSCLIN PEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/841648
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841648
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/841648 | MUSCLIN PEPTIDES AND METHODS OF USE THEREOF | Dec 13, 2017 | Abandoned |
Array
(
[id] => 15055333
[patent_doc_number] => 10457957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Insecticidal proteins and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/840073
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 33521
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840073
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/840073 | Insecticidal proteins and methods of use | Dec 12, 2017 | Issued |
Array
(
[id] => 17953496
[patent_doc_number] => 11479587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Cationic intrinsically disordered antimicrobial peptides
[patent_app_type] => utility
[patent_app_number] => 16/462498
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 19423
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462498 | Cationic intrinsically disordered antimicrobial peptides | Nov 14, 2017 | Issued |
Array
(
[id] => 15083239
[patent_doc_number] => 20190336430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => COMPOSITIONS AND METHODS FOR BLOCKING ULTRAVIOLET RADIATION
[patent_app_type] => utility
[patent_app_number] => 16/349448
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349448 | Compositions and methods for blocking ultraviolet radiation | Nov 12, 2017 | Issued |
Array
(
[id] => 12603474
[patent_doc_number] => 20180092988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS
[patent_app_type] => utility
[patent_app_number] => 15/807034
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807034
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807034 | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs | Nov 7, 2017 | Issued |
Array
(
[id] => 12231971
[patent_doc_number] => 20180064834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'Targeted Enzymatic Degradation Of Quorum-Sensing Peptides'
[patent_app_type] => utility
[patent_app_number] => 15/802817
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8410
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/802817 | Targeted enzymatic degradation of quorum-sensing peptides | Nov 2, 2017 | Issued |
Array
(
[id] => 16305349
[patent_doc_number] => 10774127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Peptide dual agonists of GIPR and GLP2R
[patent_app_type] => utility
[patent_app_number] => 16/341082
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16907
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341082
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341082 | Peptide dual agonists of GIPR and GLP2R | Oct 11, 2017 | Issued |
Array
(
[id] => 12621582
[patent_doc_number] => 20180099024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHODS, COMPOSITIONS, AND KITS INVOLVING ALTERATION OF THE CHAPERONE PROTEIN AXIS IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 15/726224
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15726224
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/726224 | METHODS, COMPOSITIONS, AND KITS INVOLVING ALTERATION OF THE CHAPERONE PROTEIN AXIS IN A SUBJECT | Oct 4, 2017 | Abandoned |
Array
(
[id] => 12157413
[patent_doc_number] => 20180028678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'SELF-ASSEMBLING COMPLEX FOR TARGETING CHEMICAL AGENTS TO CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/703323
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 11743
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703323
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703323 | Self-assembling complex for targeting chemical agents to cells | Sep 12, 2017 | Issued |
Array
(
[id] => 17323824
[patent_doc_number] => 11214820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Functionally modified polypeptides and radiobiosynthesis
[patent_app_type] => utility
[patent_app_number] => 15/695831
[patent_app_country] => US
[patent_app_date] => 2017-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 15117
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/695831 | Functionally modified polypeptides and radiobiosynthesis | Sep 4, 2017 | Issued |
Array
(
[id] => 15963107
[patent_doc_number] => 20200165305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => USE OF CGRP RECEPTOR ANTAGONISTS IN NEUROPROTECTION AND NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/329596
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329596 | Use of CGRP receptor antagonists in neuroprotection and neurological disorders | Aug 29, 2017 | Issued |
Array
(
[id] => 12219178
[patent_doc_number] => 20180057538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'POTENT AND HIGHLY SOLUBLE PEGYLATED COMPSTATIN PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/685364
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13249
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685364
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/685364 | POTENT AND HIGHLY SOLUBLE PEGYLATED COMPSTATIN PEPTIDES | Aug 23, 2017 | Abandoned |
Array
(
[id] => 16428289
[patent_doc_number] => 10828350
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-11-10
[patent_title] => Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
[patent_app_type] => utility
[patent_app_number] => 15/679896
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 16984
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679896
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679896 | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment | Aug 16, 2017 | Issued |
Array
(
[id] => 12178673
[patent_doc_number] => 20180037609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'PHASE TRANSITION BIOPOLYMERS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/679751
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 17000
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679751 | PHASE TRANSITION BIOPOLYMERS AND METHODS OF USE | Aug 16, 2017 | Abandoned |
Array
(
[id] => 13289241
[patent_doc_number] => 10155796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
[patent_app_type] => utility
[patent_app_number] => 15/661699
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 56
[patent_no_of_words] => 15828
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/661699 | Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5 | Jul 26, 2017 | Issued |